Chronological vs Biological Age in Interventional Cardiology
JACC: Cardiovascular Interventions · 2024-04 · 17 (8) · 961-978
DOI: 10.1016/j.jcin.2024.01.284 ↗Kurz gefasst
Übersichtsarbeit in der Zeitschrift JACC: Cardiovascular Interventions, 2024-04. Verfasst von Abdulla A Damluji und 7 weiteren Autor:innen. Beteiligte Einrichtung: Inova Center of Outcomes Research, Fairfax, Virginia, USA; Johns Hopkins University School of Medicine, Baltimore, Maryland, USA. Hauptthemen laut MEDLINE: Aging, Cardiovascular Diseases. Die Arbeit wurde bisher 55-mal zitiert (Crossref) und nennt 159 Literaturangaben. Der Volltext ist frei in PubMed Central verfügbar. Gefördert von: NIA NIH HHS, NHLBI NIH HHS, NHLBI.
Abstract (Originalsprache)
Aging is the gradual decline in physical and physiological functioning leading to increased susceptibility to stressors and chronic illnesses, including cardiovascular disease. With an aging global population, in which 1 in 6 individuals will be older than 60 years by 2030, interventional cardiologists are increasingly involved in providing complex care for older individuals. Although procedural aspects remain their main clinical focus, interventionalists frequently encounter age-associated risks that influence eligibility for invasive care, decision making during the intervention, procedural adverse events, and long-term management decisions. The unprecedented growth in transcatheter interventions, especially for structural heart diseases at extremes of age, have pushed age-related risks and implications for cardiovascular care to the forefront. In this JACC state-of-the-art review, the authors provide a comprehensive overview of the aging process as it relates to cardiovascular interventions, with special emphasis on the difference between chronological and biological aging. The authors also address key considerations to improve health outcomes for older patients during and after their invasive cardiovascular care. The role of "gerotherapeutics" in interventional cardiology, technological innovation in measuring biological aging, and the integration of patient-centered outcomes in the older adult population are also discussed.
Schlagwörter
MeSH-Schlagwörter (MEDLINE)
Stichwörter der Autor:innen
Autor:innen und Institutionen
- Inova Center of Outcomes Research, Fairfax, Virginia, USA; Johns Hopkins University School of Medicine, Baltimore, Maryland, USA.
- Yale University School of Medicine, New Haven, Connecticut, USA.
- Duke University School of Medicine, Durham, North Carolina USA.
- Brigham and Women's Hospital, Harvard Medical School, Boston, Massachusetts, USA.
- Vanderbilt University Medical Center, Nashville, Tennessee, USA.
- Massachusetts General Hospital, Boston, Massachusetts, USA.
Förderung
- NIA NIH HHS
- NHLBI NIH HHS
- NHLBI
- American Heart Association
- American College of Cardiology Foundation
Zitieren
APA
Damluji, A. A., Nanna, M. G., Rymer, J., Kochar, A., Lowenstern, A., Baron, S. J., Narins, C. R., & Alkhouli, M. (2024). Chronological vs Biological Age in Interventional Cardiology. JACC: Cardiovascular Interventions, 17(8), 961-978. https://doi.org/10.1016/j.jcin.2024.01.284
Vancouver
Damluji AA, Nanna MG, Rymer J, Kochar A, Lowenstern A, Baron SJ, et al. Chronological vs Biological Age in Interventional Cardiology. JACC: Cardiovascular Interventions. 2024;17(8):961-978. doi:10.1016/j.jcin.2024.01.284
BibTeX
@article{Damluji2024,
author = {Damluji, Abdulla A and Nanna, Michael G and Rymer, Jennifer and Kochar, Ajar and Lowenstern, Angela and Baron, Suzanne J and Narins, Craig R and Alkhouli, Mohamad},
title = {Chronological vs Biological Age in Interventional Cardiology},
journal = {JACC: Cardiovascular Interventions},
year = {2024},
volume = {17},
number = {8},
pages = {961--978},
doi = {10.1016/j.jcin.2024.01.284}
}
EUVIMED